Why does chemotherapy stop affecting the cells of ovarian and breast tumors?Why does chemotherapy stop affecting the
cells of
ovarian and
breast tumors?
Expression of peroxiredoxin 1, 2, 3, and 6 genes in cancer cells during drug resistance formation erythroleukemia K652, human
breast carcinoma MCF-7, and human
ovarian carcinoma SKOV-3
cells during cisplatin
ASSOCIATION OF 22 POTENTIAL PATHOGENIC VARIANTS OF NEW CANDIDATE GENES AND THE RISK OF OVARIAN CANCERMingazheva, E.T.,
Prokofyeva, D.S.,
Valova, Ya.V.,
Andreeva, E.A.,
Nurgalieva, A.Kh.,
Valiev, R.R.,
Ekomasova, N.V.,
Faishanova, R.R.,
Romanova, A.R.,
Khusnutdinova, E.K. 2, CHEK2 and NBN genes,
potentially pathogenic genetic variants in new
breast and
ovarian cancer MIR-25 IS UP-REGULATED IN OVARIAN CANCER AND PROMOTES CELL PROLIFERATION AND MOTILITYMIR-25 IS UP-REGULATED IN
OVARIAN CANCER AND PROMOTES
CELL PROLIFERATION AND MOTILITY
Oxidative Stress and Redox-Dependent Signaling in Prostate CancerRNAs in the modulation of
redox status of
cancer cells in prostate
cancer. © 2022, Pleiades Publishing, Ltd.